NPC at #ISPORAnnual
National Pharmaceutical Council experts to participate in panel discussions and research presentations at #ISPORAnnual, May 7-10, 2023.
The National Pharmaceutical Council will participate in the upcoming ISPOR 2023 conference to be held in Boston, May 7-10, 2023. Look for members of the team at the following events and sessions! View the full conference program on the ISPOR 2023 webpage.
Monday, May 8
8:30 AM - 9:45 AM | Welcome and First Plenary Session: Global Focus on Affordability and Inward Investment – What Does It Mean for HEOR?
NPC's John. M. O'Brien, PharmD, MPH will join panelists to examine measures implemented by governments to manage affordability of medicines and encourage inward investments, and the impact of these efforts on the traditional HEOR approach of valuing patient benefit and cost at the level of an individual medicine.
1:45 PM - 2:45 PM | Exploring Alternative Payment Models for Medications: Disrupting Traditional Payment Methods
Dr. O'Brien will also participate in a roundtable discussion on innovative payment methods for medications in the United States. The panel will discuss medication payment models and emerging trends.
2:45 PM - 3:30 PM | Student and New Professional Reception: Career Catalyst in Health Policy and Pharmacoeconomics
NPC is proud to sponsor the Student and New Professional Reception. NPC's Julie Patterson, PharmD, PhD, will help foster discussion on how students and early career professionals can shape the future of health policy with pharmacoeconomics.
Tuesday, May 9
12:15 PM - 1:15 PM | Poster Session: How Has Commercial Coverage of Specialty Drugs Changed Over Time?
Authors, including NPC's Rochelle Henderson, present findings of a study examining health plan use of utilization management (UM) tools to guide their enrollees’ access to specialty drugs between 2017 and 2021.
4:45 PM - 5:45 PM | A Debate on How Best to Value and Pay for Cell and Gene Therapies: Should Cost Savings Be Shared With the Health System and Society?
NPC's Robert J. Nordyke, PhD, MS will serve on this panel aimed at addressing how best to value single and short-term therapies in value assessments, when the standard of care is not priced to value. The panel will be followed by a discussion group from 5:45 - 6:45 PM.
4:45 PM - 5:45 PM | Why Is Specialty Drug Coverage Becoming More Restrictive?
Dr. Henderson will join this panel to discuss the increasing use of coverage restrictions by health plans, the potential reasons for this trend, and its consequences for patients and other health care stakeholders.